ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
ORIGINAL RESEARCH
Correlation of microembolism risk factors with age in the ischemic stroke recovery period
About authors
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia
Correspondence should be addressed: Ekaterina Vladimirovna Orlova
Ostrovityanova, 1/10, k. А8-008, Moscow, 117513, Russia; moc.liamg@kylhs.aniretake
About paper
Funding: State Assignment No. 388-00083-22-00 of 30.12.2021, research project No. 122022100113-7 of 21 February 2022
Author contribution: Orlova EV — literature review, manuscript writing, working with the database, analysis of the results; Berdalin AB — working with the dataset, statistical processing of the results, part in writing the results and the discussion; Lelyuk VG — study planning and management, search for sources of funding, manuscript editing.
Compliance with ethical standards: the study was approved by the Ethics Committee of the Federal Center of Brain and Neurotechnologies of FMBA of Russia (protocol № 01/24-10-22 of 24 October 2022); the informed consent was submitted by all study participants.
Received: 2022-10-28
Accepted: 2022-11-29
Published online: 2022-12-12
|
Fig. 1. Mixed-effects linear model of the impact of age and AF on the MES power
Fig. 2. Mixed-effects linear model of the impact of age and stroke type on the power and duration of MES. А. Mixed-effects linear model of the impact of age and stroke type on the power of MES. B. Mixed-effects linear model of the impact of age and stroke type on the duration of MES
Fig. 3. Mixed-effects linear model of the impact of age and ASPs in the right and left CCA on the MES power. А. Mixed-effects linear model of the impact of age and ASPs in the right CCA on the MES power. B. Mixed-effects linear model of the impact of age and ASPs in the left CCA on the MES power
Table 1. Basic information about the subjects enrolled
Table 2. Information about the carotid artery stenosis severity in the patients enrolled
Table 3. Biophysical characteristics and the number of MES
Table 4. Biophysical characteristics of MES in patients having or not having AF
